OCTA Analysis In Children After Lensectomy

January 2, 2020 updated by: Yune Zhao, Wenzhou Medical University

Optical Coherence Tomography Angiography Analysis After Childhood Lensectomy

The aim of this study is to quantify and compare the foveal avascular zone (FAZ), the parafoveal and foveal vessel density of superficial (SCP) and deep capillary plexus (DCP) and retinal thickness in deprivation amblyopic eyes, fellow non-amblyopic eyes, and age-matched normal eyes, using optical coherence tomography angiography (OCTA). The FAZ, parafoveal and foveal SCP and DCP, and retinal thickness were measured in normal controls and at least 3 months postoperatively in children with unilateral cataract and compared between groups after adjusting for axial length and spherical equivalents.

Study Overview

Status

Unknown

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Zhejiang
      • Hangzhou, Zhejiang, China, 325027
        • Recruiting
        • Eye Hospital of WMU
        • Contact:
      • Wenzhou, Zhejiang, China, 325027
        • Recruiting
        • The Affiliated Eye Hospital of Wenzhou Medical College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • children after cataract surgery and healthy volunteers

Exclusion Criteria:

  • presence of corneal opacity preventing detailed imaging
  • nystagmus
  • retinal disease,
  • persistent fetal vasculature
  • intraocular inflammation,
  • glaucoma
  • vitreoretinal surgery
  • premature birth
  • neurologic disease
  • systemic disease that could alter microvasculature (including diabetes, hypertension, cardiovascular disease and renal disease)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Eyes post-lensectomy
Eyes of children after cataract surgery
A device testing the vascular density in the retina
No Intervention: Healthy Eyes
Eyes of healthy volunteers

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Foveal retinal thickness
Time Frame: up to 36 months
Foveal retinal thickness in microns
up to 36 months
Area of foveal avascular zone
Time Frame: up to 36 months
Area of foveal avascular zone in square microns
up to 36 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yune Zhao, MD, Eye Hospital of WMU

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2017

Primary Completion (Anticipated)

December 1, 2020

Study Completion (Anticipated)

December 1, 2021

Study Registration Dates

First Submitted

December 29, 2019

First Submitted That Met QC Criteria

January 2, 2020

First Posted (Actual)

January 3, 2020

Study Record Updates

Last Update Posted (Actual)

January 3, 2020

Last Update Submitted That Met QC Criteria

January 2, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Deprivation Amblyopia

Clinical Trials on Optical Coherence Tomography Angiography

3
Subscribe